Berry Genomics Co.,Ltd
000710.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.99B
Close$
$-0.50
104.8% downside
Current Fair Value
104.8% downsideOvervalued by 104.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.99 Billion |
|---|---|
| Enterprise Value | $4.02 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.58 |
| Beta | 0.48 |
| Outstanding Shares | 353,521,465 |
Return
| Return on Equity | -15.02% |
|---|---|
| Return on Assets | -9.88% |
| Return on Invested Capital | -12.24% |
Valuation & Multiples
| P/E Ratio | -18.22 |
|---|---|
| PEG | -110.42 |
| Price to Sales | 5.21 |
| Price to Book Ratio | 2.6 |
| Enterprise Value to Revenue | 4.32 |
| Enterprise Value to EBIT | -20.16 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Berry Genomics Co.,Ltd
1,331 employees
CEO: Yang Gao Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testin...